Potassium News and Research

RSS
Study uncovers a biological cause for persistent taste loss after COVID-19

Study uncovers a biological cause for persistent taste loss after COVID-19

Weight-loss drugs may reduce heart damage after heart attack

Weight-loss drugs may reduce heart damage after heart attack

Metabolite-driven AI model accurately estimates time of death

Metabolite-driven AI model accurately estimates time of death

Tiny organism offers insight into neurological side effects of chemotherapy

Tiny organism offers insight into neurological side effects of chemotherapy

Long-term omeprazole use linked to mineral imbalance risks

Long-term omeprazole use linked to mineral imbalance risks

Why the carnivore diet’s claimed benefits don’t outweigh its health risks

Why the carnivore diet’s claimed benefits don’t outweigh its health risks

Research suggests bamboo-based foods could support metabolic health

Research suggests bamboo-based foods could support metabolic health

Common food preservatives may raise cancer risk

Common food preservatives may raise cancer risk

Dietary exposure to food preservatives associated with higher cancer incidence

Dietary exposure to food preservatives associated with higher cancer incidence

Higher intake of food preservatives linked to increased risk of type 2 diabetes

Higher intake of food preservatives linked to increased risk of type 2 diabetes

Small shifts in blood sodium may influence human brain excitability

Small shifts in blood sodium may influence human brain excitability

Simple fruit granola intervention shows promising cardio-renal signals in CKD patients

Simple fruit granola intervention shows promising cardio-renal signals in CKD patients

Autoimmune attack on CASPR2 drives nerve hyperexcitability and involuntary muscle activity

Autoimmune attack on CASPR2 drives nerve hyperexcitability and involuntary muscle activity

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis

Sweat testing could transform drug monitoring and diabetes care

Sweat testing could transform drug monitoring and diabetes care

AI model ranks genetic variants from severe to mild disease mutations

AI model ranks genetic variants from severe to mild disease mutations

Common nerve pain drugs may set off prescribing cascades in older patients

Common nerve pain drugs may set off prescribing cascades in older patients

Why potatoes and grains can’t replace each other in a healthy diet

Why potatoes and grains can’t replace each other in a healthy diet

Ultraprocessed diets affect teens and young adults differently

Ultraprocessed diets affect teens and young adults differently

Are mushrooms more than a low-calorie food? New analysis explains their hidden advantages

Are mushrooms more than a low-calorie food? New analysis explains their hidden advantages

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.